State Street Corp Repligen Corp Call Options Transaction History
State Street Corp
- $2.59 Trillion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RGEN
# of Institutions
503Shares Held
58.7MCall Options Held
89.3KPut Options Held
679K-
Black Rock Inc. New York, NY7.57MShares$861 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.6MShares$751 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$577 Million0.01% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.91MShares$218 Million0.53% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.4MShares$159 Million1.29% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $6.31B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....